Salesforce enters its fiscal Q2 2027 earnings release with one metric overshadowing nearly every other number: current remaining performance obligation, or cRPO. While Wall Street expects revenue of about $11.32 billion and adjusted earnings per share of $3.27, investors are watching whether contracted future revenue can validate management’s promise of stronger growth in the second half of the year.
The pressure is high because Salesforce shares were trading near $203.35 ahead of the report, down almost 30% from a year earlier and roughly 24% below their 52-week high of $269.11. Even with Agentforce annual recurring revenue reaching $1.2 billion, the market remains unconvinced that AI products are accelerating the broader business.
The debate is no longer about whether Salesforce has credible AI offerings. It is about whether those offerings are creating incremental revenue in a company guiding to only 6% to 7% organic growth excluding Informatica.
Key Facts
- Salesforce is expected to report fiscal Q2 2027 revenue of about $11.32 billion to $11.33 billion, up roughly 10.5% to 11% year over year.
- Adjusted earnings per share are forecast at $3.27, compared with revenue of $11.13 billion and adjusted EPS of $3.88 in fiscal Q1 2027.
- Investors are looking for cRPO of about $33.41 billion and growth around 14% to support a second-half reacceleration story.
- Agentforce ARR reached $1.2 billion in fiscal Q1 2027, up 205% year over year, while combined AI and data ARR climbed to $3.4 billion.
- Salesforce traded around 14.76 times forward earnings, below many software peers, with a consensus analyst target near $242.64.
Salesforce cRPO and Organic Growth
The central issue for Salesforce is the gap between reported growth and organic growth. Consensus points to another quarter of double-digit revenue expansion, but guidance suggests that, excluding the Informatica contribution, organic growth may slow to roughly 6% to 7%. For a company still valued as a major enterprise software platform, that is a meaningful deceleration.
That makes cRPO especially important. Because the metric captures contracted revenue not yet recognized, it acts as a forward indicator for sales trends over the next two to three quarters. If Salesforce posts cRPO growth at or above 14% and guides Q3 cRPO growth in the 13% to 14% range, investors may take that as evidence that bookings momentum is strong enough to support faster revenue growth later in fiscal 2027.
If the number falls short, the market may conclude that enthusiasm around Agentforce and Data Cloud is real but not yet broad enough to change the company’s growth profile. In that scenario, Salesforce could beat quarterly expectations and still face pressure if investors view AI demand as substituting for legacy seat-based subscriptions rather than adding to them.
Salesforce does not need another earnings beat; it needs proof that future contracted revenue is strong enough to turn AI momentum into broader growth.
Why AI Strength Has Not Settled the Debate
Salesforce’s AI numbers are substantial by any standard. Agentforce ARR of $1.2 billion and combined AI and data ARR of $3.4 billion show that the company has built a meaningful new business quickly. Management has also highlighted that about half of Agentforce and Data 360 bookings have come from existing customers expanding their spend, a sign that the installed base remains a strategic advantage.
Still, scale matters. Against trailing 12-month revenue of $42.83 billion, Agentforce remains a relatively small contributor. Even rapid growth from this base may not fully offset slower expansion in core products if enterprise budgets tighten or customers shift spending from traditional licenses toward AI tools inside the same ecosystem.
Implications for Investors
For investors, the setup is unusually sensitive to guidance and forward indicators rather than headline earnings. Prediction markets and analyst models have suggested a high probability of an earnings beat, which reduces the impact of a routine upside surprise. What matters more is whether Salesforce can show that bookings, subscription demand, and AI adoption are lining up in a way that supports stronger growth in the back half of the fiscal year.
Valuation offers part of the bull case. Salesforce’s forward earnings multiple of about 14.76x sits well below many software peers, despite operating margin of 34.8%, trailing net income of $8.02 billion, and significant free cash flow generation. The company also has $25 billion remaining on its buyback authorization, which could provide support if management remains aggressive on capital returns.
But the risk is equally clear. Options markets were pricing an earnings move of about 8%, wider than the stock’s average post-earnings move over the past four quarters. That reflects uncertainty around whether the company is entering a new AI-driven growth cycle or settling into a mature, slower-growth phase. Investors should watch cRPO growth, Q3 guidance, commentary on customer refills and AI consumption, and any signs that small and mid-sized customers are lengthening buying cycles.
The next move in Salesforce stock is likely to depend less on what the company earned in the quarter and more on what management can prove about demand already in the pipeline. If cRPO confirms stronger bookings, the stock may have room to re-rate toward the $242 area; if not, the market may keep treating AI progress as promising but not yet transformative.